IT1208
IT1208 is a humanized anti-CD4 monoclonal IgG1 antibody. IT1208 depletes CD4+ T cells with a manageable safety profile in vivo. IT1208 can be used for colon cancer research.
商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。
-
保管条件:
Please store the product under the recommended conditions in the Certificate of Analysis.
生物活性
製品説明
Species Reactivity
Human
IC50 & Target
CD4
体内実験
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Animal Model:Human B cell lymphoma Raji cells (1 × 106, i.p.) induced-mice prior to Healthy human peripheral blood mononuclear cells (PBMCs) (20 × 106, i.p.)[2]
-
Dosage:200 μg
-
Administration:i.p., twice a week for 4 weeks
-
Result:Effectively prevented the development of xenogeneic GVHD in mice in experiments using cells from 3 donors.
Exerted only a partial preventive effect on xenogeneic GVHD in mice in the experiment using cells from 1 single donor.
Significantly prevented GVHD-associated damage to target tissues including the skin, salivary glands, liver and lung in mice.
遺伝子ID
アクセッション番号
Conjugated
Unconjugated
Reconsititution
The product can be reconstituted/diluted with sterile PBS or saline.
Format
-
Product Image
アプリケーション
ELISA, FACS, Functional assay
化学情報
-
Formulation
Please refer to the lot-specific COA for specific buffer information.
-
保管条件
Please store the product under the recommended conditions in the Certificate of Analysis.
純度とドキュメンテーション
参考文献
[1]. Shitara K, et al., Matsushima K, Doi T. First-in-human phase 1 study of IT1208, a defucosylated humanized anti-CD4 depleting antibody, in patients with advanced solid tumors. J Immunother Cancer. 2019 Jul 24;7(1):195. [Content Brief]
[2]. Liu M, Yang J, Xu B, Zhang X. Tumor metastasis: Mechanistic insights and therapeutic interventions. MedComm (2020). 2021 Dec 2;2(4):587-617. [Content Brief]
Calculators
濃度 (開始) × 体積 (開始) = 濃度 (終了) × 体積 (終了)